Zurcher Kantonalbank Zurich Cantonalbank Acquires 2,902 Shares of Paragon 28, Inc. (NYSE:FNA)

Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Paragon 28, Inc. (NYSE:FNAFree Report) by 26.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,886 shares of the company’s stock after purchasing an additional 2,902 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Paragon 28 were worth $173,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. Bank of New York Mellon Corp increased its holdings in Paragon 28 by 2.4% during the third quarter. Bank of New York Mellon Corp now owns 154,134 shares of the company’s stock worth $1,934,000 after buying an additional 3,615 shares during the last quarter. HighMark Wealth Management LLC bought a new position in shares of Paragon 28 during the 4th quarter valued at approximately $99,000. Panagora Asset Management Inc. purchased a new stake in shares of Paragon 28 during the 3rd quarter worth approximately $142,000. Loomis Sayles & Co. L P raised its holdings in shares of Paragon 28 by 1.2% in the 3rd quarter. Loomis Sayles & Co. L P now owns 1,584,749 shares of the company’s stock worth $19,888,000 after purchasing an additional 19,321 shares during the period. Finally, Jump Financial LLC purchased a new position in Paragon 28 in the third quarter valued at approximately $272,000. 63.57% of the stock is currently owned by institutional investors.

Insider Transactions at Paragon 28

In other news, insider Albert Dacosta bought 28,000 shares of the firm’s stock in a transaction that occurred on Friday, March 15th. The shares were acquired at an average price of $9.12 per share, with a total value of $255,360.00. Following the acquisition, the insider now owns 5,339,110 shares of the company’s stock, valued at approximately $48,692,683.20. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 15.32% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Needham & Company LLC reissued a “buy” rating and issued a $17.00 target price on shares of Paragon 28 in a research report on Thursday, April 4th. Piper Sandler restated an “overweight” rating and issued a $18.00 price objective on shares of Paragon 28 in a research note on Wednesday, March 27th. Finally, Stephens reiterated an “overweight” rating and set a $18.00 target price on shares of Paragon 28 in a research report on Friday, April 5th.

View Our Latest Stock Report on FNA

Paragon 28 Trading Down 1.4 %

NYSE:FNA opened at $10.53 on Wednesday. Paragon 28, Inc. has a 1 year low of $7.95 and a 1 year high of $19.00. The stock’s fifty day moving average price is $10.36 and its two-hundred day moving average price is $11.14. The company has a debt-to-equity ratio of 0.62, a current ratio of 4.21 and a quick ratio of 2.30. The company has a market cap of $872.63 million, a P/E ratio of -18.15 and a beta of 1.12.

Paragon 28 (NYSE:FNAGet Free Report) last released its quarterly earnings data on Thursday, February 29th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.09). Paragon 28 had a negative net margin of 22.11% and a negative return on equity of 22.51%. The company had revenue of $60.56 million for the quarter, compared to the consensus estimate of $60.73 million. As a group, analysts expect that Paragon 28, Inc. will post -0.43 EPS for the current year.

Paragon 28 Profile

(Free Report)

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.

See Also

Want to see what other hedge funds are holding FNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Paragon 28, Inc. (NYSE:FNAFree Report).

Institutional Ownership by Quarter for Paragon 28 (NYSE:FNA)

Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.